236 related articles for article (PubMed ID: 6452278)
41. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
Deutsch O; Devens B; Naor D
Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
[TBL] [Abstract][Full Text] [Related]
42. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
Fujii T; Igarashi T; Kishimoto S
J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
[TBL] [Abstract][Full Text] [Related]
43. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
44. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
Koyama S; Yoshioka T; Sakita T
Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
[TBL] [Abstract][Full Text] [Related]
45. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
Shu SY; Chou T; Rosenberg SA
J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
[TBL] [Abstract][Full Text] [Related]
46. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
[TBL] [Abstract][Full Text] [Related]
47. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
48. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
49. [T-suppressors from tumor-bearing mice inhibit antitumor cytotoxic T-lymphocytes in monoculture].
Lupatov AIu; Brondz BD
Biull Eksp Biol Med; 1992 Feb; 113(2):186-7. PubMed ID: 1535235
[TBL] [Abstract][Full Text] [Related]
50. Natural suppressor cell inhibiting T killer responses against retroviruses: a model for self tolerance.
Tilkin AF; Bègue B; Gomard E; Levy JP
J Immunol; 1985 Apr; 134(4):2779-82. PubMed ID: 3156190
[TBL] [Abstract][Full Text] [Related]
51. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
Becker S; Haskill S
J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
[TBL] [Abstract][Full Text] [Related]
52. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
[TBL] [Abstract][Full Text] [Related]
53. In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.
Forni G; Giovarelli M
J Immunol; 1984 Jan; 132(1):527-33. PubMed ID: 6228583
[TBL] [Abstract][Full Text] [Related]
54. Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus-induced tumors.
Gomard E; Levy JP; Plata F; Henin Y; Duprez V; Bismuth A; Reme T
Eur J Immunol; 1978 Apr; 8(4):228-36. PubMed ID: 78851
[No Abstract] [Full Text] [Related]
55. Original H-2d and alien H-2k-like antigens of a BALB/c fibrosarcoma as defined by in vitro and in vivo studies of cell-mediated immunity.
Sensi M; Carbone G; Parmiani G
Eur J Immunol; 1980 Sep; 10(9):671-8. PubMed ID: 6158452
[No Abstract] [Full Text] [Related]
56. Induction of murine T cell lymphoma expressing specific cytotoxic activity.
Schaaf-Lafontaine N; Martin MT; Boniver J
Eur J Immunol; 1986 Mar; 16(3):320-3. PubMed ID: 3007167
[TBL] [Abstract][Full Text] [Related]
57. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
[TBL] [Abstract][Full Text] [Related]
58. Specific suppression elicited by EL4 lymphoma cells in syngeneic mice. Specificity includes self-antigens on EL4.
Grooten J; Leroux-Roels G; Fiers W
Eur J Immunol; 1987 May; 17(5):605-11. PubMed ID: 2953613
[TBL] [Abstract][Full Text] [Related]
59. Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism.
Cihak J; Lehmann-Grube F
Immunology; 1978 Feb; 34(2):265-75. PubMed ID: 304840
[TBL] [Abstract][Full Text] [Related]
60. Distribution of in vitro-stimulated immune lymphocytes in mice bearing Moloney murine sarcoma virus-induced primary tumor.
Kimura H; Yamaguchi Y
Gan; 1981 Feb; 72(1):72-80. PubMed ID: 7274651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
